[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK86588A - Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof - Google Patents

Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof

Info

Publication number
HK86588A
HK86588A HK865/88A HK86588A HK86588A HK 86588 A HK86588 A HK 86588A HK 865/88 A HK865/88 A HK 865/88A HK 86588 A HK86588 A HK 86588A HK 86588 A HK86588 A HK 86588A
Authority
HK
Hong Kong
Prior art keywords
preparation
composition
pharmaceutical preparations
solid pharmaceutical
active vitamins
Prior art date
Application number
HK865/88A
Inventor
Yuji Makino
Yoshiki Suzuki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of HK86588A publication Critical patent/HK86588A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G47/00—Article or material-handling devices associated with conveyors; Methods employing such devices
    • B65G47/02—Devices for feeding articles or materials to conveyors
    • B65G47/04—Devices for feeding articles or materials to conveyors for feeding articles
    • B65G47/12—Devices for feeding articles or materials to conveyors for feeding articles from disorderly-arranged article piles or from loose assemblages of articles
    • B65G47/14—Devices for feeding articles or materials to conveyors for feeding articles from disorderly-arranged article piles or from loose assemblages of articles arranging or orientating the articles by mechanical or pneumatic means during feeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
HK865/88A 1983-02-22 1988-10-27 Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof HK86588A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58026898A JPS59155309A (en) 1983-02-22 1983-02-22 Active type vitamin d3 composition and its preparation

Publications (1)

Publication Number Publication Date
HK86588A true HK86588A (en) 1988-11-04

Family

ID=12206053

Family Applications (1)

Application Number Title Priority Date Filing Date
HK865/88A HK86588A (en) 1983-02-22 1988-10-27 Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof

Country Status (7)

Country Link
US (1) US4729895A (en)
EP (1) EP0116755B1 (en)
JP (1) JPS59155309A (en)
KR (1) KR880001095B1 (en)
DE (1) DE3372845D1 (en)
HK (1) HK86588A (en)
MY (1) MY101847A (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149619A (en) * 1985-09-05 1987-07-03 Teijin Ltd Injection composition of active type vitamin d3
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
JP2643222B2 (en) * 1988-02-03 1997-08-20 エーザイ株式会社 Multi-layer granules
US5182274A (en) * 1988-09-26 1993-01-26 Teijin Limited Stabilized aqueous preparation of active form of vitamin d3
JP2525478B2 (en) * 1989-03-01 1996-08-21 帝人株式会社 Active Vitamin D with improved stability (3) Lower solid preparation
US5258375A (en) * 1989-03-13 1993-11-02 Ss Pharmaceutical Co., Ltd. Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate
JP2845342B2 (en) * 1990-04-28 1999-01-13 大正製薬株式会社 Vitamin D Lower 3 Derivative-Containing Solid Preparation Composition
JPH04198129A (en) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd Active type vitamin d>=3*s-containing composition
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
CA2065603C (en) * 1991-04-09 2007-04-03 Hiroki Itoh Stabilized vitamin d preparation
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
WO1997011703A1 (en) * 1995-09-28 1997-04-03 Teijin Limited Preventive or remedy for hyperthyreosis
DE10127897B4 (en) * 2001-06-08 2006-04-20 Bionorica Ag Coated tablet with dry plant extracts
KR100688618B1 (en) * 2001-09-12 2007-03-09 주식회사 유유 A pharmaceutical composition of vitamin D compound using controlled delivery
WO2007019418A1 (en) * 2005-08-08 2007-02-15 Sun Chemical Corporation Ir-luminescent nanocomposite pigment and sol-gel process for manufacturing thereof
JP5303276B2 (en) * 2005-10-12 2013-10-02 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー Methods and products for treating 25-hydroxyvitamin D deficiency and deficiency
HUE029572T2 (en) 2006-02-03 2017-03-28 Opko Renal Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PL2037936T3 (en) 2006-06-21 2015-04-30 Opko Renal Llc Method of treating and preventing secondary hyperparathyroidism
EP3335712A1 (en) 2007-04-25 2018-06-20 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US11752158B2 (en) * 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
EP3342405B1 (en) 2007-04-25 2019-08-21 Opko Ireland Global Holdings, Ltd. Controlled release 25-hydroxyvitamin d
CA2587805C (en) * 2007-04-25 2014-02-18 The Procter & Gamble Company Improved vitamin d content uniformity in pharmaceutical dosage forms
EP2148685A4 (en) * 2007-04-25 2010-07-28 Cytochroma Inc Methods and compounds for vitamin d therapy
CA2713765A1 (en) * 2008-02-06 2009-08-13 Innov'ia Pulverulent composition and a process for preparing the same
KR101685031B1 (en) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
ES2783980T3 (en) 2010-03-29 2020-09-21 Opko Ireland Global Holdings Ltd Methods and compositions for the reduction of parathyroid levels
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN104800185B (en) * 2015-04-22 2018-03-09 青岛正大海尔制药有限公司 Alfacalcidol sustained release tablets and preparation method thereof
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
CN110121348A (en) * 2016-12-28 2019-08-13 中外制药株式会社 The pharmaceutical composition of solid dispersions and oil dispersion comprising ED-71
BR112021003788A2 (en) 2018-08-31 2021-06-08 Opko Ireland Global Holdings, Ltd. pediatric dosage forms, manufacturing methods and vitamin d use

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2691619A (en) * 1951-09-18 1954-10-12 Pfizer & Co C Fat-soluble vitamin-containing products and process therefor
GB799068A (en) * 1955-12-29 1958-07-30 Hoffmann La Roche A stabilized vitamin-d composition and a process for the production thereof
GB1027675A (en) * 1963-01-07 1966-04-27 Henry Joseph Johnson Fortifying composition for water-base liquid food products
DE1492034A1 (en) * 1965-05-18 1969-02-20 Merck Ag E Process for the production of solid, long-lasting preparations of sensitive active substances that are poorly soluble in water, preferably pharmaceuticals
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US3957966A (en) * 1972-05-19 1976-05-18 Gaf Corporation Stabilized vitamin food coatings
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
JPS5418330B2 (en) * 1973-03-16 1979-07-06
JPS58401B2 (en) * 1974-07-15 1983-01-06 明治製菓株式会社 The antlers of the world
JPS5225015A (en) * 1975-08-22 1977-02-24 Sumitomo Chem Co Ltd Process for preparing fine granular drugs
SE418247B (en) * 1975-11-17 1981-05-18 Haessle Ab SET TO MAKE BODIES WITH REGULATED RELEASE OF AN ACTIVE COMPONENT
FR2389377A1 (en) * 1977-05-06 1978-12-01 Brohult Johan Antiinflammatory, antirheumatic medicament - comprises 1 alpha-hydroxy-cholecalciferol
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS54135218A (en) * 1978-04-11 1979-10-20 Yamanouchi Pharmaceut Co Ltd Composition containing prostaglandin e
JPS5569562A (en) * 1978-11-21 1980-05-26 Teijin Ltd Stabilization of active vitamin d3 derivative
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
IL67881A0 (en) * 1982-02-12 1983-06-15 Sparamedica Ag Pharmaceutical compositions including certain cholecalciferol derivatives

Also Published As

Publication number Publication date
MY101847A (en) 1992-01-31
DE3372845D1 (en) 1987-09-10
JPS59155309A (en) 1984-09-04
US4729895A (en) 1988-03-08
KR880001095B1 (en) 1988-06-29
JPS6360007B2 (en) 1988-11-22
EP0116755B1 (en) 1987-08-05
EP0116755A1 (en) 1984-08-29
KR850000238A (en) 1985-02-26

Similar Documents

Publication Publication Date Title
DE3372845D1 (en) Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
ZA849373B (en) Method and composition for the preparation of controlled longacting pharmaceuticals for oral administration
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
PT85329A (en) Process for the preparation of tetrahydronaphtaline and indane derivatives and of pharmaceutical compositions containing the same
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
PT86365A (en) Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same
PT80731B (en) Process for the preparation of pharmacollogically active substiuted benzamides and pharmaceutical compositions therewith
PT86516A (en) Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same
PT82984A (en) Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
IL69543A (en) Derivatives of omega-amino acids,their preparation and pharmaceutical compositions containing them
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
PT83495A (en) Process for the preparation of n-substituted diphenylpiperidines and of pharmaceutical compositions containing the same
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
HU900608D0 (en) Process for preparation of lactame-derivatives and pharmaceutical preparations containing them
PT83188A (en) Process for the preparation of benzimidazole derivatives and of pharmaceutical compositions containing the same
PT82399A (en) Process for the preparation of phenethanolamine derivatives and of pharmaceutical compositions containing the same
PT83565A (en) Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same
PT82855A (en) Process for the preparation of glucopyranoses phosphonated and pharmaceutical compositions therewith
PT79858B (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
PT80824B (en) Process for the preparation of phenylquinoline derivatives and of pharmaceutical compositions containing the same
HUT44770A (en) Process for producing 6-phenoxymethyl-4-hydroxy-tetrahydropyran-2-one derivatives and pharmaceutical preparations comprising them as active substance

Legal Events

Date Code Title Description
PE Patent expired